Opana er and Arthropathy - a phase IV clinical study of FDA data

Summary:

Arthropathy is reported as a side effect among people who take Opana er (oxymorphone hydrochloride), especially for people who are female, 60+ old, also take Prednisone, and have Bronchitis.

The phase IV clinical study analyzes which people have Arthropathy when taking Opana er. It is created by eHealthMe based on reports of 33,673 people who have side effects when taking Opana er from the FDA, and is updated regularly.

What is Opana er?

Opana er has active ingredients of oxymorphone hydrochloride. It is often used in pain. eHealthMe is studying from 33,986 Opana er users. Check the latest studies of Opana er.

What is Arthropathy?

Arthropathy is found to be associated with 1,609 drugs and 1,682 conditions by eHealthMe. Check the latest studies of Arthropathy.

On Jul, 15, 2026

33,673 people reported to have side effects when taking Opana er.
Among them, 12 people (0.04%) have Arthropathy.

Among these 12 people:

What is the gender of people who have Arthropathy when taking Opana er? *

female: 91.67 %
male: 8.33 %

What is the age of people who have Arthropathy when taking Opana er? *

What are other drugs people take besides Opana er? *

What are other side effects people have besides Arthropathy? *

Fall: 4 people, 33.33%
Joint Pain: 4 people, 33.33%
Weakness: 3 people, 25.00%
Oedema Peripheral (superficial swelling): 3 people, 25.00%
Muscle Strain (an injury to a muscle in which the muscle fibres tear): 2 people, 16.67%
Heart Attack: 2 people, 16.67%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 2 people, 16.67%
Upper Limb Fracture: 2 people, 16.67%
Drug Ineffective: 2 people, 16.67%
Disturbance In Attention: 2 people, 16.67%

What are the existing conditions these people have? *

Pneumonia: 2 people, 16.67%
Parkinson's Disease: 2 people, 16.67%
High Blood Cholesterol: 2 people, 16.67%
Depression: 2 people, 16.67%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 16.67%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 16.67%
Sleep Disorder: 1 person, 8.33%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 8.33%
Neuropathy Peripheral (surface nerve damage): 1 person, 8.33%
Neuralgia (pain in one or more nerves): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Opana er and have Arthropathy?

- Check whether Arthropathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Opana er:

Opana er (33,986 reports)

Arthropathy treatments and more:

Arthropathy (75,984 reports)

Browse all side effects of Opana er:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Arthropathy:

Arthropathy (1,609 drugs)

Browse all the conditions that are associated with Arthropathy:

Arthropathy (1,682 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on oxymorphone hydrochloride (the active ingredients of Opana er) and Opana er (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.